Neurology: Volume 90, Number 16, April 17, 2018 Exam #1 - Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor

About this course

  • Released: 04/17/2018
  • Expires: 04/17/2021


CLINICAL AND PATHOGENIC SIGNIFICANCE OF IgG, IgA, AND IgM ANTIBODIES AGAINST THE NMDA RECEPTOR

LEARNING OBJECTIVES:

Upon completion of the article by Hara et al, the participant should be able to:

  • Discuss the effect of exposing cultured neurons to anti-N-methyl-
  • D-aspartate receptor (NMDAR) receptor antibodies of different classes observed in this study
  • Describe the most common clinical presentation of patients in this study with IgG anti-NMDAR antibodies
  • State what percentage of healthy control subjects had anti-NMDAR antibodies in this study
     

CORE COMPETENCIES:

The article by Hara et al covers the following core competency:

  • Medical Knowledge
     

AUTHOR DISCLOSURES:

Refer to Information and Author section available in the Tool Bar for each article.

 

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

AMA CREDIT DESIGNATION STATEMENT

The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURES

James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology. Adam Kelly, MD, has served as a guest editor of Continuum (April 2014) and receives a stipend in his editorial capacity for Neurology.

COMMERCIAL SUPPORT

This CME program receives no commercial support.

ACCME